No Data
Express News | Yesterday, 31 stocks had a net buy financing of over 0.1 billion yuan, with chongqing sokon industry group stock net buying 0.64 billion yuan.
Kangmei Pharmaceutical (600518.SH) has seen no major changes in its fundamentals, and its profitability still needs further recovery.
Gelonghui November 11th | Kangmei Pharmaceutical (600518.SH) announced that on November 11, 2024, the company's stocks continued to hit the limit up, with a significant short-term increase in stock prices. In the first three quarters of 2024, the company achieved revenue of 3873.5583 million yuan, with a net income attributable to shareholders of the listed company of 5.0155 million yuan, and a net income attributable to shareholders of the listed company after deducting non-recurring gains and losses of -179.5222 million yuan. The company's production operation is currently normal, and the fundamentals have not undergone significant changes, with profitability still needing further recovery. The board of directors of the company confirmed, in addition to what has been publicly disclosed.
Express News | Kangmei Pharmaceutical: The company's stock price has experienced a significant short-term increase. Investors are advised to pay attention to the risks.
Express News | The largest increase in margin trading balance this week: HoLuc Bo margin trading balance: 0.22 billion yuan, with a balance growth rate of 949.58%; Kangmei Pharmaceutical margin trading balance: 0.732 billion yuan, with a balance growth rate of 166.12%.
Express News | Kangmei Pharmaceutical has been continuously trading at the limit: there is no significant information that should be disclosed but has not been disclosed.
Major MSCI adjustment! Brokerage stocks are most favored, 20 companies are being removed.
On November 7th, Beijing time, the international index compiler MSCI announced the results of the November stock index review. Among them, 4 Chinese stocks were newly included in the MSCI China Index, while 20 individual stocks were removed. All changes will take effect after the market closes on November 25, 2024.
No Data
No Data